log dose-response curves graphpad prism version 8.2.1 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
log dose-response curves graphpad prism version 8.2.1
Log Dose Response Curves Graphpad Prism Version 8.2.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+dose-response+curves+graphpad+prism+version+8%2E2%2E1/graphpad+prism+software/pmc09132777-160-18-21
Average 90 stars, based on 1 article reviews
Log Dose Response Curves Graphpad Prism Version 8.2.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+dose-response+curves+graphpad+prism+version+8%2E2%2E1/graphpad+prism+software/pmc09132777-160-18-21
Average 90 stars, based on 1 article reviews
log dose-response curves graphpad prism version 8.2.1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial Article Snippet: The half-maximal inhibitory concentration (IC 50 ) for in-vitro lumefantrine susceptibility was determined by nonlinear regression of the Article Title: Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial Article Snippet: The half-maximal inhibitory concentration (IC50) for invitro lumefantrine susceptibility was determined by nonlinear regression of the |